Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Indications for thrombolytics].

B Charbonnier¹

¹Cardiologie D et unité de soins cardiaques intensifs, CHRU de Tours, Hôpital Trousseau.

La Revue Du Praticien

|December 3, 1999

Summary

Thrombolytic drugs are crucial for treating acute myocardial infarction and pulmonary embolism. Newer agents like alteplase offer significant benefits, especially when administered early, but carry risks such as cerebral bleeding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase and size separations occurring during the injection of model pastes composed of β-tricalcium phosphate powder, glass beads and aqueous solutions.

Acta biomaterialia·2013

Same author

Continuum generated by chromatic dispersion and power variations in periodically amplified soliton links.

Optics letters·2009

Same author

Effect of time to treatment and age on one year mortality in acute STEMI: difference between thrombolysis and primary percutaneous coronary intervention.

Archives of cardiovascular diseases·2008

Same author

[Exercise deep venous thrombosis: myth or reality? About three cases of pulmonary embolism in long-distance runners].

Archives des maladies du coeur et des vaisseaux·2007

Same author

[Dilated cardiomyopathy, diabetes and deafness related to a mutation of mitochondrial DNA].

Archives des maladies du coeur et des vaisseaux·2007

Same author

Postcardiac injury syndrome complicating radiofrequency ablation of the atrioventricular node.

Acute cardiac care·2006

Area of Science:

Cardiology
Vascular Medicine
Pharmacology

Context:

Thrombolytic therapy has evolved significantly from initial agents like streptokinase and urokinase.
Newer thrombolytics such as alteplase, reteplase, lanoteplase, and saruplase represent advancements, particularly in acute myocardial infarction.
The efficacy of thrombolysis is time-sensitive, with critical windows for optimal outcomes.

Purpose:

To review the current applications and efficacy of thrombolytic drugs in various cardiovascular and cerebrovascular conditions.
To highlight the benefits and risks associated with different thrombolytic agents.
To discuss the indications and controversies surrounding thrombolytic therapy in specific clinical scenarios.

Summary:

Thrombolytic drugs are effective in acute myocardial infarction, with early treatment (within 1-6 hours) significantly reducing mortality.
Alteplase and reteplase show high efficacy but increase the risk of cerebral bleeding.
Thrombolysis is indicated for severe pulmonary embolism and considered for acute ischemic stroke within 3 hours and prosthetic heart valve thrombosis when surgery is contraindicated.

Impact:

Early thrombolytic administration can halve mortality rates in acute myocardial infarction.
The strategic use of thrombolytics improves patient outcomes in critical conditions like pulmonary embolism and ischemic stroke.
Careful consideration of risks, such as bleeding, is essential when selecting thrombolytic agents and patient populations.

Related Experiment Videos